Novolean combines two potent peptides, AOD-9604 and SLU-PP-332, designed to support fat loss, metabolic function, and cellular regeneration. AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone (hGH), while SLU-PP-332 is a proprietary compound that has been studied for its synergistic effects on fat metabolism. This combination, presented in a 1mL concentration (100mcg AOD-9604 + 500mcg SLU-PP-332), is designed for research into fat-burning, metabolic regulation, and tissue repair.
Both peptides in Novolean are under investigation for their effects on lipolysis (fat breakdown), metabolic enhancement, and cellular regeneration. When combined, these compounds may offer a multifaceted approach to metabolic health and fat loss. Key features of Novolean include:
Sublingual delivery methods (or injectable options) of Novolean may allow for more rapid absorption and improved bioavailability in research applications.
The combination of these peptides may have significant implications in obesity research, weight management studies, and fat-burning protocols.
Novolean (AOD-9604 + SLU-PP-332) is for research purposes only. It is not for human consumption, medical use, or diagnostic applications. All information provided is intended for scientific and educational research only.
LP10 FOR 10% OFF YOUR ORDER